Tohoku University Tohoku Medical Megabank Organization (Akihito Otsuki)
2020.01.21

1.   Otsuki Akihito, Yamamoto Masayuki. Cis-element architecture of Nrf2-sMaf heterodimer binding sites and its relation to diseases. Archives of pharmacal research. 2019; : . doi:10.1007/s12272-019-01193-2  
2.   Keleku-Lukwete Nadine, Suzuki Mikiko, Panda Harit, et al. Nrf2 activation in myeloid cells and endothelial cells differentially mitigates sickle cell disease pathology in mice. Blood advances. 2019; 3 (8): 1285-1297. doi:10.1182/bloodadvances.2018017574  
3.   Tadaka Shu, Katsuoka Fumiki, Ueki Masao, et al. 3.5KJPNv2: an allele frequency panel of 3552 Japanese individuals including the X chromosome. Human Genome Variation. 2019; 6 (1): 28. doi:10.1038/s41439-019-0059-5  
4.   Katsuoka Fumiki, Otsuki Akihito, Takahashi Mizue, et al. Direct and Specific Functional Evaluation of the Nrf2 and MafG Heterodimer by Introducing a Tethered Dimer into Small Maf-Deficient Cells. Molecular and Cellular Biology. 2019; 39 (20): . doi:10.1128/MCB.00273-19  
5.   Yasuda Jun, Kinoshita Kengo, Katsuoka Fumiki, et al. Genome analyses for the Tohoku Medical Megabank Project towards establishment of personalized healthcare. The Journal of Biochemistry. 2019; 165 (2): 139-158. doi:10.1093/jb/mvy096  
6.   Katayama Saori, Suzuki Mikiko, Yamaoka Ayaka, et al. GATA2 haploinsufficiency accelerates EVI1-driven leukemogenesis. Blood. 2017; 130 (7): 908-919. doi:10.1182/blood-2016-12-756767